Sedana Medical AB (publ)

DB:7D2A Stock Report

Market Cap: €202.6m

Sedana Medical Management

Management criteria checks 2/4

Sedana Medical's CEO is Johannes Doll, appointed in Oct 2021, has a tenure of 2.67 years. total yearly compensation is SEK5.24M, comprised of 62.2% salary and 37.8% bonuses, including company stock and options. directly owns 0.12% of the company’s shares, worth €239.90K. The average tenure of the management team and the board of directors is 2.2 years and 2.1 years respectively.

Key information

Johannes Doll

Chief executive officer

SEK 5.2m

Total compensation

CEO salary percentage62.2%
CEO tenure2.7yrs
CEO ownership0.1%
Management average tenure2.2yrs
Board average tenure2.1yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Johannes Doll's remuneration changed compared to Sedana Medical's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2024n/an/a

-SEK 23m

Dec 31 2023SEK 5mSEK 3m

-SEK 60m

Sep 30 2023n/an/a

-SEK 57m

Jun 30 2023n/an/a

-SEK 58m

Mar 31 2023n/an/a

-SEK 71m

Dec 31 2022SEK 5mSEK 3m

-SEK 74m

Sep 30 2022n/an/a

-SEK 54m

Jun 30 2022n/an/a

-SEK 62m

Mar 31 2022n/an/a

-SEK 68m

Dec 31 2021SEK 5mSEK 1m

-SEK 58m

Compensation vs Market: Johannes's total compensation ($USD494.86K) is below average for companies of similar size in the German market ($USD757.90K).

Compensation vs Earnings: Johannes's compensation has increased whilst the company is unprofitable.


CEO

Johannes Doll (43 yo)

2.7yrs

Tenure

SEK 5,244,000

Compensation

Mr. Johannes Doll serves as Chief Executive Officer and President at Sedana Medical AB (publ) since October 01, 2021. Mr. Doll had been Executive Vice President and Chief Commercial Officer at Orexo AB (pu...


Leadership Team

NamePositionTenureCompensationOwnership
Johannes Doll
CEO & President2.7yrsSEK 5.24m0.12%
SEK 239.9k
Johan Spetz
Chief Financial Officer2.2yrsno data0.12%
SEK 234.7k
Karolina Vilval
General Counsel1.8yrsno datano data
Peter Sackey
Chief Medical Officer6.4yrsno data0.23%
SEK 468.0k
Linda Frölén
Head of Group Financeno datano datano data
Anders Ersson
Head of International Markets2yrsno data0.0050%
SEK 10.2k
Clarisa Mogollón
Chief Commercial Officerless than a yearno datano data
Jessica Westfal
VP of Regulatory Affairs and QA4.1yrsno data0.00070%
SEK 1.4k
Uwe Veismann
GM for Germanyless than a yearno datano data
Stefan Krisch
Supply Chain & Manufacturing Director3.3yrsno data0.0056%
SEK 11.4k

2.2yrs

Average Tenure

47yo

Average Age

Experienced Management: 7D2A's management team is considered experienced (2.2 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Claus Bjerre
Chairman of the Board3.1yrsSEK 545.00kno data
Donna Haire
Directorless than a yearno datano data
Jens Viebke
Directorless than a yearno datano data
Hilde Furberg
Independent Director2.1yrsSEK 242.00k0.0045%
SEK 9.2k
Christoffer Rosenblad
Independent Director4.1yrsSEK 317.00k0.010%
SEK 20.4k

2.1yrs

Average Tenure

55yo

Average Age

Experienced Board: 7D2A's board of directors are not considered experienced ( 2.1 years average tenure), which suggests a new board.


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.